TB

This document is intended to raise awareness about TB/HIV research priorities (i.e. areas that require urgent funding and scientific interest), help coordinate advocacy efforts, and encourage research funding. The aim is to increase the implementation of high-quality, integrated TB/HIV interventions in resource-limited settings. The document outlines a revised research priority agenda based on the latest evidence in six key areas of TB and HIV co-infection.

The purpose of this document is to highlight cases in which Advocacy, Communication and Social Mobilization (ACSM) interventions have contributed to a positive outcome of tuberculosis (TB) control activities directed to a range of audiences and settings. It is intended for on-the-ground stakeholders who are interested in successfully integrating ACSM strategies and activities into TB control programming, as well as for decision-makers who can provide greater political and financial support for ACSM activities at the national, sub-national and international level.

This document addresses a broad range of ethical issues arising in TB programmes, ranging from informed consent and isolation to health-care workers' rights and obligations, and clinical and epidemiological studies.

This guide aims to improve case detection, management, and outcomes of children with TB.

This December 2009 presentation aims to foster reflection on and a debate about the role of communication in addressing tuberculosis (TB). The authors propose a conceptual framework of communication and its relation to ethics, building from previous experience in order work against stigma and discrimination in health care contexts by developing the advocacy, communication, and social mobilisation (ACSM) model.

This Medscape CDC Expert Video Commentary features Rear Admiral Kenneth Castro, MD discussing the new IGRA guidelines.

The Checklist is designed to provide CHWs, supervisors, and program managers (from NTPs, NGOs, CBOs, and others) with very practical ways to properly implement TB IC and to minimize risk of transmission within community residential settings, including families and households.

This fact sheet provides basic information on the TB skin test.

Drs. Jacques Grosset and Timothy Sterling will discuss the rationale for and potential new approaches to treatment of TB in HIV-infected individuals. Primary and secondary resistance of TB medications and the role of therapeutic drug monitoring for HIV-infected patients will be explored. The application of research to clinical practice will be highlighted.

This advocacy brochure shows how one million lives can be saved by the end of 2015 by preventing and treating tuberculosis among people living with HIV.